Gary Zieziula
Direttore/Membro del Consiglio presso INNOVENT BIOLOGICS, INC.
Patrimonio netto: 23 851 $ in data 30/04/2024
Posizioni attive di Gary Zieziula
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INNOVENT BIOLOGICS, INC. | Direttore/Membro del Consiglio | 31/05/2022 | - |
| Independent Dir/Board Member | 31/05/2022 | - |
Storia della carriera di Gary Zieziula
Precedenti posizioni note di Gary Zieziula
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2014 | - |
| Presidente | - | 01/09/2018 | |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28/04/2010 | 04/11/2011 |
| MERCK & CO., INC. | Vendite & Marketing | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Vendite & Marketing | - | - |
Formazione di Gary Zieziula
| Canisius College | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Isole Cayman | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 2 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Borsa valori
- Insiders
- Gary Zieziula
- Esperienza